X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemotherapy (5) 5
female (5) 5
humans (5) 5
male (5) 5
oncology (5) 5
aged (4) 4
lung neoplasms - pathology (4) 4
middle aged (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
bevacizumab (3) 3
cancer (3) 3
carcinoma, non-small-cell lung - pathology (3) 3
care and treatment (3) 3
hematology, oncology and palliative medicine (3) 3
index medicus (3) 3
japan (3) 3
lung neoplasms - drug therapy (3) 3
neoplasm staging (3) 3
adult (2) 2
aged, 80 and over (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
carcinoma, non-small-cell lung - mortality (2) 2
carcinoma, squamous cell - drug therapy (2) 2
carcinoma, squamous cell - mortality (2) 2
carcinoma, squamous cell - pathology (2) 2
cisplatin (2) 2
clinical trials (2) 2
combination (2) 2
disease-free survival (2) 2
intention to treat analysis (2) 2
kaplan-meier estimate (2) 2
lung cancer (2) 2
lung neoplasms - mortality (2) 2
placebo (2) 2
treatment outcome (2) 2
1st-line therapy (1) 1
5-fluorouracil (1) 1
adenocarcinoma (1) 1
adolescent (1) 1
adverse events (1) 1
analysis (1) 1
angiogenesis (1) 1
anorexia (1) 1
antibiotics, antineoplastic - administration & dosage (1) 1
antibiotics, antineoplastic - adverse effects (1) 1
antibiotics, antineoplastic - therapeutic use (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
asymptomatic brain metastases (1) 1
bayesian analysis (1) 1
biomedicine (1) 1
brain neoplasms - diagnostic imaging (1) 1
brain neoplasms - prevention & control (1) 1
brain neoplasms - secondary (1) 1
brain research (1) 1
bronchi - pathology (1) 1
cancer patients (1) 1
cancer research (1) 1
cancer therapies (1) 1
capecitabine (1) 1
carboplatin (1) 1
carcinoma, non-small-cell lung - genetics (1) 1
carcinoma, non-small-cell lung - surgery (1) 1
carcinoma, squamous cell - genetics (1) 1
cell survival (1) 1
cisplatin - adverse effects (1) 1
cisplatin - therapeutic use (1) 1
cisplatin plus gemcitabine (1) 1
cohort studies (1) 1
college teachers (1) 1
colon-cancer (1) 1
colorectal cancer (1) 1
complete remission (1) 1
confidence intervals (1) 1
cranial irradiation - adverse effects (1) 1
cross infection (1) 1
development and progression (1) 1
diagnosis (1) 1
disease progression (1) 1
dissection (1) 1
dose-response relationship, drug (1) 1
double-blind (1) 1
drug administration schedule (1) 1
drug combinations (1) 1
drug eruptions - epidemiology (1) 1
drug therapy (1) 1
early termination of clinical trials (1) 1
ebus-tbna (1) 1
efficacy (1) 1
endobronchial ultrasound (1) 1
endoscopic ultrasound-guided fine needle aspiration - methods (1) 1
erlotinib (1) 1
erlotinib hydrochloride (1) 1
expression (1) 1
feasibility studies (1) 1
fluorouracil plus leucovorin (1) 1
folfox (1) 1
gastric cancer (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 663 - 671
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1630 - 1638
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1236 - 1244
Summary Background With use of EGFR tyrosine-kinase inhibitor monotherapy for patients with activating EGFR mutation-positive non-small-cell lung cancer... 
Hematology, Oncology and Palliative Medicine | TRIAL | GROWTH-FACTOR RECEPTOR | CISPLATIN PLUS GEMCITABINE | PLACEBO | EFFICACY | NSCLC | ONCOLOGY | ADENOCARCINOMA | DOUBLE-BLIND | COMBINATION | CHEMOTHERAPY | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Confidence Intervals | Prognosis | Lung Neoplasms - mortality | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Receptor, Epidermal Growth Factor - drug effects | Lung Neoplasms - pathology | Male | Bevacizumab | Dose-Response Relationship, Drug | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Squamous Cell - mortality | Neoplasm Invasiveness - pathology | Female | Quinazolines - administration & dosage | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Drug Administration Schedule | Carcinoma, Non-Small-Cell Lung - genetics | Japan | Kaplan-Meier Estimate | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Maximum Tolerated Dose | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Neoplasm Staging | Development and progression | Care and treatment | Cross infection | Nosocomial infections | Erlotinib | Lung cancer, Non-small cell
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 2/2008, Volume 61, Issue 2, pp. 335 - 343
Journal Article
Journal of Translational Medicine, 01/2014, Volume 12
  Doc number: 108 Abstract Background: We previously conducted a phase I trial for advanced colorectal cancer (CRC) using five HLA-A*2402-restricted peptides,... 
Chemotherapy | Peptides | Lymphocytes | Drug therapy
Journal Article
JOURNAL OF TRANSLATIONAL MEDICINE, ISSN 1479-5876, 04/2014, Volume 12
Background: We previously conducted a phase I trial for advanced colorectal cancer (CRC) using five HLA-A*2402-restricted peptides, three derived from... 
MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNE-RESPONSE | ANGIOGENESIS | BEVACIZUMAB | Colorectal cancer | Peptide cocktail | Peptide vaccine | IDENTIFICATION | Phase II study | Chemotherapy | PLUS OXALIPLATIN | IMMUNOTHERAPY | REGULATORY T-CELLS | LUNG-DISEASE | FOLFOX | JAPANESE PATIENTS | EXPRESSION
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.